|
|
Sold Out
Book Categories |
| 1 | High-volume screening | 3 |
| 2 | High-throughput screening in industry | 23 |
| 3 | The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications | 41 |
| 4 | Human tumor screening | 63 |
| 5 | Murine L1210 and P388 leukemias | 79 |
| 6 | In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery | |
| 7 | Human tumor xenograft models in NCI drug development | 125 |
| 8 | NCI specialized procedures in preclinical drug evaluations | 153 |
| 9 | Patient-like orthotopic metastatic models of human cancer | 183 |
| 10 | Preclinical models for combination therapy | 213 |
| 11 | Models for biomarkers and minimal residual tumor | 243 |
| 12 | Spontaneously occurring tumors in companion animals as models for drug development | 259 |
| 13 | Nonclinical testing: from theory to practice | 287 |
| 14 | Nonclinical testing for oncology drug products | 313 |
| 15 | Nonclinical testing for oncology biologic products | 325 |
| 16 | Working with the national cancer institute | 339 |
| 17 | Phase I trial design and methodology for anticancer drugs | 351 |
| 18 | Phase II trials: conventional design and novel strategies in the era of targeted therapies | 363 |
| 19 | Drug development in europe: the academic perspective | 381 |
| 20 | The phase III clinical cancer trial | 401 |
| 21 | Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective | 411 |
| 22 | The role of the oncology drug advisory committee in the FDA review process for oncologic products | 421 |
| 23 | FDA role in cancer drug development and requirements for approval | 429 |
| Price | Condition | Delivery | Seller | Action |
| $211.06 | Digital |
| WonderClub |
Glynis Sakowicz
reviewed Anticancer Drug Development Guide on August 22, 2010
Anticancer Drug Development Guide
Hard to read if you've been through the NICU with a premature baby but a very good book....one to be shared with obstetricians and neonatologists to raise awareness that the impacts of prematurity don't end when you walk out the NICU door. Ruth is a tireless warrior for premature infants and their families and her book is fantastic.
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish List
X
This item is in your Collection
Anticancer Drug Development Guide
X
This Item is in Your Inventory
Anticancer Drug Development Guide
X
You must be logged in to review the productsX
X
X
Add Anticancer Drug Development Guide, This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of, Anticancer Drug Development Guide to the inventory that you are selling on WonderClubX
X
Add Anticancer Drug Development Guide, This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of, Anticancer Drug Development Guide to your collection on WonderClub |
